sarcoidosis%20-%20pulmonary
SARCOIDOSIS - PULMONARY
Sarcoidosis is a multisystem disease which may present with non-specific symptoms or symptoms related to organ-specific involvement.
Non-specific symptoms include fever, malaise, fatigue and weight loss.
Pulmonary involvement is seen in >90% of sarcoidosis patients.

Diagnosis

  • Diagnosis is often delayed because of the usual non-specific presentation

Diagnosis is based on the following:

  • Compatible clinical or radiologic picture or both
  • Histologic proof of non-caseating granuloma
  • Exclusion of similar diseases

Staging

Staging of Pulmonary Sarcoidosis based on Chest X-ray (CXR)

Stage 0

  • Normal CXR

Stage 1

  • Lymphadenopathy
    • Hilar & paratracheal nodes are usually involved
    • Parenchymal granulomas may be found on biopsy even in the absence of infiltrates on CXR

Stage 2

  • Lymphadenopathy w/ parenchymal infiltrates

Stage 3

  • Parenchymal infiltration w/o lymphadenopathy
  • Progressive loss of lung function may occur

Stage 4

  • Advanced fibrosis
  • Other findings include emphysema, bullae, cysts, hilar retraction & honey-combing
  • Progressive loss of lung function may occur

History

  • A thorough clinical history & physical exam should be obtained
  • Though the cause of sarcoidosis is unknown, the patient should be questioned carefully about exposure to both inorganic & organic antigens
  • Investigate possible environmental & occupational exposures that may reveal an alternative diagnosis
    • Exposure to metal dusts, fumes & organic antigens may cause granulomatous diseases that are difficult to differentiate from sarcoidosis

Extrapulmonary Disease

  • Physical exam should include a search for evidence of extrapulmonary disease
    • Evidence of multi-organ involvement is supportive of a diagnosis of sarcoidosis

Laboratory Tests

Biopsy & Histology

  • Transbronchial lung biopsy to demonstrate granulomas is recommended in most cases
    • Has a higher yield for patients w/ parenchymal lung disease seen on CXR or CT scan
  • Accessible skin lesions &/or lymph nodes may also be biopsied
  • Surgical biopsy is indicated when transbronchial or bronchial biopsies are not diagnostic & no other accessible biopsy sites are identified

Other Diagnostic Procedures/Laboratory Exams

Bronchoalveolar Lavage (BAL)

  • Increased lymphocytes are seen or an increased CD4:CD8 ratio
  • Findings are supportive, but not definitive of a diagnosis

Angiotensin Converting Enzyme (ACE) Levels

  • Elevations are not diagnostic since other diseases & granulomatous conditions may present w/ high levels of ACE
  • Additional evaluation is recommended in all patients diagnosed w/ sarcoidosis

Laboratory Exams

  • Pulmonary function tests
    • Spirometry
    • Diffusing capacity for carbon monoxide (DLco)
  • Peripheral blood counts
  • Serum chemistries
    • Blood urea nitrogen (BUN), creatinine, calcium
    • Liver enzymes: Aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP) 
  • Urinalysis
    • Patients may present w/ hypercalciuria
  • Electrocardiogram (ECG)
    • Patients may manifest w/ cardiac arrhythmias
  • Routine ophthalmologic evaluation
    • To determine if eye involvement is present
  • Tuberculin test

Imaging

Chest X-ray (CXR)

  • Presence of bilateral hilar enlargement may speed up the diagnostic process
  • Interstitial disease alone may be seen

Computed Tomography (CT) scan

  • May be used to identify patients w/ parenchymal disease not seen on CXR
  • Demonstrates hilar & mediastinal lymphadenopathy
  • May also be done when patients present w/ atypical clinical or radiologic findings
  • Allows detection of complications of the disease (eg bronchiectasis, aspergilloma, pulmonary fibrosis)
  • Consider CT when there is clinical suspicion of the disease but the CXR is normal

Total Body Gallium Scan

  • Appearance of a Panda pattern combined w/ a Lambda pattern may support diagnosis
  • Findings are present only in a small number of patients
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
22 May 2017
Chronic obstructive pulmonary disease (COPD) is currently the 10th commonest cause of death in Singapore, with a disease burden of 5.9 percent according to a 2015 population-based survey (EPIC-Asia survey) in Singapore. Pearl Toh spoke with Dr Augustine Tee, chief and senior consultant of the Department of Respiratory and Critical Care Medicine at Changi General Hospital (CGH) in Singapore, on how COPD is often underdetected in the primary care population as symptoms are not specific and diagnosis requires a combination of clinical risk factors, symptoms and spirometry testing.
15 Aug 2017
New drug applications approved by US FDA as of 1 - 15 August 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
04 Aug 2017
Chronic obstructive pulmonary disease (COPD) is the fourth cause of global mortality, with experts predicting a potential future rise in the prevalence rates of COPD. 
11 May 2016

In conjunction with World Asthma Day which falls on 3rd May 2016, MIMS Doctor speaks to a renowned respiratory medicine specialist, Dato' Dr. Hj Abdul Razak Abdul Muttalif, regarding the chronic airway disease.